St. Jude sues to block former exec from joining rival; China Kanghui registers for IPO;

> St. Jude Medical believes a former top executive with access to "copious amounts" of confidential information violated an employment agreement by leaving and quickly joining heart-device rival Medtronic. Item

 > China Kanghui Holdings, a medical-device maker, registered for an initial public offering of American depositary shares of up to $75 million. Report

> U.S. Marshals have seized $346,954.43 worth of FastSize Extender devices and FastSize EQM Erectile Quality Monitor devices, as well as component parts used in the manufacture of the FastSize Extender. The products are misbranded and adulterated because they, among other things, are unapproved and were manufactured under conditions that did not meet cGMP requirements. Release

> Volcano Corporation says it will vigorously defend against the patent infringement lawsuit filed against it by St. Jude Medical in federal district court in Delaware. Volcano believes that the claims against it are entirely without merit, and looks forward to vindicating its rights in court. Release

> AirStrip Technologies, a pioneer in mobile medical software applications, has announced that it has received FDA clearance to market the AirStrip Remote Patient Monitoring solution (RPM), including AirStrip RPM CRITICAL CARE and AirStrip RPM CARDIOLOGY. Release

> To plug it in and keep it beating, these two agencies must keep on meeting was the general theme of a panel discussion Monday convened by the FCC and FDA to address the current state of wireless health, and the lessons learned in those fields. Report

> Mammotome CEO Tom Daulton views his new medical products company acquired from Johnson & Johnson's Ethicon Endo-Surgery like building a house. Daulton, with a $250 million investment from Chicago private equity firm GTCR Golder Rauner, envisions building a much larger medical products company over the next several years, one with revenues of at least $500 million on the foundation of the Mammotome breast biopsy business. Report

> Mediomics has received an additional $460,000 in a renewal of its second year STTR Phase II grant (R42GM079891) from the National Institute of General Medical Sciences. Release

> Diagnostic-technology maker Hologic (HOLX) said Tuesday that a FDA panel will review its 3-D mammography system in September, the first step in the approval process for a device that is expected to see high demand and meaningfully boost revenue. Story

> Leto Medical has announced that the United States Patent and Trademark Office has granted the company two patents (7,765,006 and 7,765,007) for its breakthrough Continent Ostomy System (COS) technology, a system of products that will restore continence control to individuals with colostomies. Release

And Finally... A unique device based on sniffing might enable numerous disabled people to navigate wheelchairs or communicate with their loved ones. Sniffing technology might even be used in the future to create a sort of ;third hand,' to assist healthy surgeons or pilots. Release

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.